Blog

$6 million supports leukemia research – Washington University School of Medicine in St. Louis


Washington University School of Medicine in St. Louis

$6 million supports leukemia research
Washington University School of Medicine in St. Louis
In this approach, the gene-editing technology also is used to remove the cellular machinery that triggers graft-versus-host disease while still allowing these genetically edited CART cells to track down and kill the T-ALL cells. Using this approach

2017-11-06 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.